Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patients

Introduction.  Chronic kidney disease (CKD) predisposes to a 10‐ to 20‐fold increased cardiovascular risk. Patients undergo accelerated atherogenesis and vascular ageing. We investigated whether telomere attrition, a marker of cell senescence, contributes to this increased mortality risk.

[1]  I. Deary,et al.  Association between telomere length and heart disease in a narrow age cohort of older people , 2007, Experimental Gerontology.

[2]  A. Aviv,et al.  Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis , 2007, Osteoporosis International.

[3]  J. Carrero,et al.  Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. , 2007, The American journal of clinical nutrition.

[4]  N. Samani,et al.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.

[5]  E. Frangou,et al.  Serum oxidized low‐density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients , 2006, Nephrology.

[6]  Vicente Andrés,et al.  Telomere Biology and Cardiovascular Disease , 2006, Circulation research.

[7]  R. Kronmal,et al.  Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. , 2006, American journal of epidemiology.

[8]  S. Czene,et al.  Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? , 2006, Antioxidants & redox signaling.

[9]  I. Deary,et al.  The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people , 2006, Neuroscience Letters.

[10]  K. Kalantar-Zadeh,et al.  The kidney disease wasting: Inflammation, oxidative stress, and diet‐gene interaction , 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

[11]  S. Chatzipanagiotou,et al.  Telomerase Activity Is Decreased in Peripheral Blood Mononuclear Cells of Hemodialysis Patients , 2006, American Journal of Nephrology.

[12]  T. von Zglinicki,et al.  Telomere Shortening and Haemodialysis , 2006, Blood Purification.

[13]  S. Sela,et al.  Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  P. Stenvinkel,et al.  Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. , 2005, Kidney international.

[15]  M. Blasco,et al.  Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  E. Epel,et al.  Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H Oikawa,et al.  Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis , 2004, Gut.

[18]  R. Effros.  T Cell Replicative Senescence Pleiotropic Effects on Human Aging , 2004, Annals of the New York Academy of Sciences.

[19]  R. Davies,et al.  Ageing and the death of neurones , 2004 .

[20]  J. Staessen,et al.  Telomere length and possible link to X chromosome , 2004, The Lancet.

[21]  A. Aviv,et al.  Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects , 2004, Hypertension.

[22]  N. Samani,et al.  White Cell Telomere Length and Risk of Premature Myocardial Infarction , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Jardine,et al.  Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. , 2003, The American journal of pathology.

[24]  G. Saretzki,et al.  Extracellular Superoxide Dismutase Is a Major Antioxidant in Human Fibroblasts and Slows Telomere Shortening* , 2003, The Journal of Biological Chemistry.

[25]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[26]  C. Wanner,et al.  Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? , 2002, Kidney international.

[27]  Peter Stenvinkel,et al.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.

[28]  S. Davies,et al.  Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[30]  I. Komuro,et al.  Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.

[31]  M. Oshimura,et al.  Telomere lengths are characteristic in each human individual , 2002, Experimental Gerontology.

[32]  N. Samani,et al.  Telomere shortening in atherosclerosis , 2001, The Lancet.

[33]  J. Skurnick,et al.  Telomere Length as an Indicator of Biological Aging: The Gender Effect and Relation With Pulse Pressure and Pulse Wave Velocity , 2001, Hypertension.

[34]  E J Topol,et al.  Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.

[35]  David Waddington,et al.  Analysis of telomere lengths in cloned sheep , 1999, Nature.

[36]  P. Stenvinkel,et al.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.

[37]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  C. Harley,et al.  Telomere length and replicative aging in human vascular tissues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. McNamee,et al.  Oxidative stress in haemodialysis. , 1994, QJM : monthly journal of the Association of Physicians.

[40]  A. Mooradian.  Antioxidant properties of steroids , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[42]  J. Pepper,et al.  Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. , 1988, British heart journal.

[43]  Sudhir V. Shah,et al.  Oxidants in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[44]  A. Jardine,et al.  Dolly, no longer the exception: telomeres and implications for transplantation. , 2003, Cloning and stem cells.

[45]  B. Lindholm,et al.  Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. , 2002, Journal of the American Society of Nephrology : JASN.

[46]  A S Detsky,et al.  What is subjective global assessment of nutritional status? , 1987, JPEN. Journal of parenteral and enteral nutrition.

[47]  L. Henderson,et al.  Hemodialysis Hypotension: The Interleukin Hypothesis , 1983 .